Current Startup and Venture Investment News as of 28 February 2026: Mega-Rounds in AI Chips, IPO and SPAC Revival, M&A Transactions, Secondary Market Activity, and Trends for Global Venture Funds. Analysis for Investors.
The end of the week marked a consolidation of two key themes defining the agenda for venture investors and LPs in 2026. Firstly, capital continues to concentrate in the infrastructure of artificial intelligence, particularly in AI chips, cloud inference infrastructure, and corporate platforms that assist businesses in reducing computational costs and expediting model deployment. Secondly, the liquidity market is showing signs of revival: a number of mature companies are returning to public listings, while alternative routes such as SPACs and secondary transactions are once again being discussed as viable portfolio management tools.
For venture funds, this indicates increased competition for 'quality' rounds (Series B–D), heightened demands on term sheets (liquidation preferences, anti-dilution clauses, option structure), and an imperative for stricter discipline regarding valuations and unit economics—especially in segments where revenue depends on computational costs and data access.
USA: AI Hardware and Corporate Platforms Driving Mega-Rounds
In the US, venture investments continue to revolve around two focal points: (1) developers of AI accelerators and inference systems, and (2) companies creating 'lanes' for the deployment of AI within corporations—from orchestration to security. Recent transactions affirm that investors are willing to pay a premium for teams capable of offering alternatives to dominant suppliers and reducing total cost of ownership (TCO) for large clients.
- AI Chips and Accelerators: significant Series B and later rounds signal market readiness to finance capital-intensive roadmaps, provided there is a chance to capture niche opportunities in inference and corporate clusters.
- Partnerships as Part of the Round: financing is increasingly accompanied by strategic agreements with major technology players, thus reducing go-to-market risk and enhancing revenue quality.
- Valuations and Expectations: investors are demanding a more transparent gross margin model, detailed delivery plans, and confirmed demand (LOIs, pilots, initial contracts) before agreeing to a 'premium' valuation.
Biotech and Medtech: IPOs as a Test of Appetite for Venture Stories
Biotech and AI medical platforms are once again in the spotlight as the public market begins to selectively accept 'venture' stories—especially when there is clinical progress and a clear monetisation roadmap. For venture investors, this is an important indicator: the IPO window may not necessarily be wide open but is selectively available for companies with strong science, defensible technology, and a transparent regulatory pathway.
- Liquidity Signal: a successful public offering increases the attractiveness of late rounds and may spur growth in the secondary market for shares in mature companies.
- Term Sheet and Round Structure: funds are increasingly proposing hybrid structures (primary + secondary) to balance risk and partially secure profits for early investors and employees.
- Valuation: multiples are becoming more 'punitive' towards projects lacking clinical/commercial milestones—disciplining the market and reducing the share of 'marketing' rounds.
Europe: More Selective Venture Investments and a Focus on Deep Tech
The European startup market maintains a high deal pace, but selectivity has noticeably increased. The focus is on deep tech (quantum technologies, cybersecurity, industrial AI), climate solutions, and applied corporate products. This presents a combination of opportunities and constraints for funds: on one hand, a strong engineering base and grant ecosystems; on the other, the necessity to build a global go-to-market strategy to maintain high valuations in later rounds.
- Quantum Companies: discussions around public market entry via SPAC raise questions regarding revenue maturity and investors' willingness to accept technological risks in exchange for long-term potential.
- Series A–C Rounds: term sheets increasingly feature stricter conditions on governance, KPIs, and investor rights, especially if a startup requires funding for 18–24 months.
- Cross-Border Strategy: companies are enhancing their presence in the US and Asia to expand their client base and support valuations in the follow-on round.
Asia and the Middle East: Sovereign Capital and 'Infrastructure' Bets
In Asia, the growing interest in AI infrastructure is bolstered by government and quasi-government programmes, as well as the activity of large corporations as strategic investors. In the Middle East, sovereign funds and corporate groups continue to act as anchor LPs and co-investors in later stages, preferring deals with a clear role for the region in the value chain (data centres, energy for computation, industrial platforms).
For global venture funds, this translates to a more complex landscape: access to capital is increasing, but demands for compliance, deal structure, and rights allocation for technologies and data are escalating.
M&A and the Secondary Market: A 'Quiet' Reboot of Liquidity
Alongside selective IPOs, the market is increasingly reverting to M&A as a functioning exit mechanism. For strategics, the primary motive is to accelerate product plans in AI and cybersecurity while acquiring teams with skills that are difficult to recruit. Concurrently, the secondary market for shares is expanding: funds and employees are more frequently considering partial sales of their stakes within late rounds to mitigate personal risk and 'unlock' capital without waiting for a complete exit.
- Corporate Buyers: are showing more interest in teams and technological modules than entire businesses, affecting deal structure and valuation.
- Secondaries: are becoming a standard option in large rounds, especially when valuations are high and there is demand from new investors.
- Valuation: for M&A, revenue quality and synergies are more critical than 'venture storytelling', thus sharpening due diligence standards.
Practice for Investors: How to Read a Term Sheet and Not Overpay for Valuation
Amidst the concentration of capital and increasing competition for the best deals, it is beneficial for funds and LPs to maintain a checklist that helps separate sustainable stories from overheated ones. This is particularly pertinent in the AI sector where computational costs and access to data directly impact margins.
- Check Computational Economics: how does the cost of inference change with scaling, and is there an optimisation strategy (model, hardware, caching, quantisation)?
- Demand and Contracts: are there commercial KPIs, not just pilots; what are the conditions for termination and expansion of contracts?
- Governance: board rights, protective provisions, budget control, approval processes for M&A.
- Liquidity: options for secondary sales, triggers for IPO/SPAC, restrictions on share transfers.
- Anti-Dilution: type (full ratchet vs weighted average), thresholds, consequences for future rounds.
What Today’s Agenda Means for Startups and Venture Funds
Saturday, 28 February 2026, marks a market pivot towards 'pragmatic growth': venture investments remain willing to finance substantial bets in AI and deep tech, but demand stricter evidence of demand and realistic liquidity exit plans. Startup teams should prepare for more detailed due diligence and pro-actively design their round structure—including secondary components, option programmes, and transparent economic models. For venture funds, the key task will be to maintain valuation discipline, carefully construct portfolios across stages, and leverage a combination of IPOs, M&A, and secondaries as tools for risk management and profitability.
